Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
S Jarius, F Aboul-Enein, P Waters, B Kuenz, A Hauser… - Brain, 2008 - academic.oup.com
Neuromyelitis optica (NMO) is a severe inflammatory CNS disorder of putative autoimmune
aetiology, which predominantly affects the spinal cord and optic nerves. Recently, a highly …
aetiology, which predominantly affects the spinal cord and optic nerves. Recently, a highly …
[HTML][HTML] Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica
F Paul, S Jarius, O Aktas, M Bluthner, O Bauer… - PLoS …, 2007 - journals.plos.org
Background Neuromyelitis optica (NMO) is a demyelinating disease of the central nervous
system (CNS) of putative autoimmune aetiology. Early discrimination between multiple …
system (CNS) of putative autoimmune aetiology. Early discrimination between multiple …
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
S Jarius, B Wildemann - Nature Reviews Neurology, 2010 - nature.com
Antibodies to aquaporin-4 (also known as AQP4-Ab or NMO-IgG) are sensitive and highly
specific serum markers of autoimmune neuromyelitis optica (NMO). Second-generation …
specific serum markers of autoimmune neuromyelitis optica (NMO). Second-generation …
[HTML][HTML] Neuromyelitis optica pathogenesis and aquaporin 4
DJ Graber, M Levy, D Kerr, WF Wade - Journal of neuroinflammation, 2008 - Springer
Neuromyelitis optica (NMO) is a severe, debilitating human disease that predominantly
features immunopathology in the optic nerves and the spinal cord. An IgG1 autoantibody …
features immunopathology in the optic nerves and the spinal cord. An IgG1 autoantibody …
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
T Misu, K Fujihara, A Kakita, H Konno, M Nakamura… - Brain, 2007 - academic.oup.com
Neuromyelitis optica (NMO) is an inflammatory and necrotizing disease clinically
characterized by selective involvement of the optic nerves and spinal cord. There has been …
characterized by selective involvement of the optic nerves and spinal cord. There has been …
[HTML][HTML] Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance
Abstract Background In 70-80% of cases, neuromyelitis optica (NMO) is associated with
highly specific serum auto-antibodies to aquaporin-4 (termed AQP4-Ab or NMO-IgG) …
highly specific serum auto-antibodies to aquaporin-4 (termed AQP4-Ab or NMO-IgG) …
[HTML][HTML] Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica
S Mader, A Lutterotti, F Di Pauli, B Kuenz, K Schanda… - PloS one, 2010 - journals.plos.org
Background Neuromyelitis optica (NMO), a severe demyelinating disease, represents itself
with optic neuritis and longitudinally extensive transverse myelitis. Serum NMO-IgG …
with optic neuritis and longitudinally extensive transverse myelitis. Serum NMO-IgG …
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
SF Roemer, JE Parisi, VA Lennon, EE Benarroch… - Brain, 2007 - academic.oup.com
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that typically affects
optic nerves and spinal cord. Its pathogenic relationship to multiple sclerosis (MS) is …
optic nerves and spinal cord. Its pathogenic relationship to multiple sclerosis (MS) is …
Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica
Neuromyelitis optica (NMO) is a rare CNS inflammatory disorder that predominantly affects
the optic nerves and spinal cord. Recent serological findings strongly suggest that NMO is a …
the optic nerves and spinal cord. Recent serological findings strongly suggest that NMO is a …
Evaluation of aquaporin‐4 antibody assays
PJ Waters, SJ Pittock, JL Bennett… - Clinical and …, 2014 - Wiley Online Library
Abstract Aquaporin‐4 (AQP 4) is a water channel protein that is most highly, but not
exclusively, expressed in the central nervous system. In 2005 AQP 4 was shown to be the …
exclusively, expressed in the central nervous system. In 2005 AQP 4 was shown to be the …